Search
Could cancer immunotherapy success depend on gut bacteria?: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/cancer-immunotherapy-gut-bacteria.html
A study by researchers revealed that gut bacteria can penetrate tumor cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.
Regenerating cells that keep the beat: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/regenerating-cells-that-keep-the-beat.html
Specialized cells that conduct electricity to keep the heart beating have a previously unrecognized ability to regenerate in the days after birth, a new study in mice by UT Southwestern researchers suggests.
UT Southwestern among top 25 in nation in eight specialties ranked by U.S. News ‘Best Hospitals’: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/us-news-best-hospital.html
UT Southwestern Medical Center ranks among the top 25 hospitals nationally in eight specialties ranging from brain to heart to cancer care, according to the latest U.S. News & World Report’s annual Best Hospitals report.
UT Southwestern immunologists uncover obesity-linked trigger to severe form of liver disease: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-obesity-linked-trigger.html
UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.
International policy adviser, epidemiologist Dr. Saad Omer selected inaugural dean for UT Southwestern’s O’Donnell School of Public Health: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-omer-inaugural-dean.html
Internationally recognized epidemiologist Saad B. Omer, M.B.B.S, Ph.D., who currently directs the Yale Institute for Global Health, has been appointed the inaugural Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center.
New drug combination offers hope for improved treatment of cervical cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-new-drug-combination.html
A new combination of drugs slowed the growth of cancer cells by an unexpected mechanism that may one day lead to improved treatment of cervical cancer, a UT Southwestern-led study published in Molecular Cancer Research suggests.
New technique improves high-intensity focused ultrasound treatment for brain disorders: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-treatment-for-brain-disorders.html
UT Southwestern physicians have developed an improved targeting method, four-tract tractography, to personalize MRI-guided, high-intensity focused ultrasound.
Breast cancer drug benefits broader group of patients, trial shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-breast-cancer-drug.html
A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.
UTSW optometrist offers optimum care guidelines for contact lens users: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-optimum-care-guidelines.html
A recent viral video showing a California ophthalmologist removing 23 contact lenses from an elderly patient’s eye has drawn attention to the importance of properly using contact lenses to ensure the health of your eyes.
Drug shows promise in overcoming endocrine therapy resistance in breast cancer : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-endocrine-therapy-resist.html
For patients with estrogen receptor (ER)-positive breast cancer, development of the so-called Y537S mutation signals that their disease has taken an aggressive course and may become resistant to endocrine therapy.